Details

Autor(en) / Beteiligte

• Wang, Shendong
• Liu, Zhaojun
• Geng, Jiafeng
• Li, Liangge
• Feng, Xiujing

Titel

An overview of ferroptosis in non-alcoholic fatty liver disease

Ist Teil von

• Biomedicine & pharmacotherapy, 2022-09, Vol.153, p.113374-113374, Article 113374

Ort / Verlag

Elsevier Masson SAS

Erscheinungsjahr

2022

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Non-alcoholic fatty liver disease (NAFLD) is a public health problem associated with high mortality and high morbidity rates worldwide. Presently, its complex pathophysiology is still unclear, and there is no specific drug to reverse NAFLD. Ferroptosis is an iron-dependent and non-apoptotic form of cell death characterized by the iron-induced accumulation of lipid reactive oxygen species (ROS), which damage nucleic acids, proteins, and lipids; generate intracellular oxidative stress; and ultimately cause cell death. Emerging evidence indicates that ferroptosis is involved in the progression of NAFLD, although the mechanism of action of ferroptosis in NAFLD is still poorly understood. Herein, we summarize the mechanism of action of ferroptosis in certain diseases, especially in the pathogenesis of NAFLD, and discuss the potential therapeutic approaches currently used to treat NAFLD. This review also highlights further directions for the treatment and prevention of NAFLD and related diseases. [Display omitted] •Non-alcoholic fatty liver disease (NAFLD) is a public health problem worldwide.•Ferroptosis is involved in the progression of NAFLD.•Potential therapeutic treatments to NAFLD via targeting ferroptosis.